Trials / Conditions / Refractory Brain Neoplasm
Refractory Brain Neoplasm
3 registered clinical trials studyying Refractory Brain Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Sol NCT02389309 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or R NCT02444546 | Mayo Clinic | Phase 1 |
| Active Not Recruiting | Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diff NCT02359565 | National Cancer Institute (NCI) | Phase 1 |